Pancreatic Cancer Research

ResearcherWuhan Union HospitalNo recent work listed

Shi-Jiang Deng

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5025874943. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 2 papers · 2017: 1 paper · 2018: 3 papers · 2019: 3 papers

Papers 10

  1. Nutrient Stress-Dysregulated Antisense lncRNA GLS-AS Impairs GLS-Mediated Metabolism and Represses Pancreatic Cancer Progression. Co-author DOI 10.1158/0008-5472.can-18-0419↗
  2. Hypoxia-induced feedback of HIF-1α and lncRNA-CF129 contributes to pancreatic cancer progression through stabilization of p53 protein. Co-author DOI 10.7150/thno.30988↗
  3. LncRNA-MTA2TR functions as a promoter in pancreatic cancer via driving deacetylation-dependent accumulation of HIF-1α. Co-author DOI 10.7150/thno.34559↗
  4. MiRNA-646-mediated reciprocal repression between HIF-1α and MIIP contributes to tumorigenesis of pancreatic cancer. Co-author DOI 10.1038/s41388-017-0082-2↗
  5. Hypoxia-induced LncRNA-BX111 promotes metastasis and progression of pancreatic cancer through regulating ZEB1 transcription. Co-author DOI 10.1038/s41388-018-0382-1↗
  6. The responsively decreased PKM2 facilitates the survival of pancreatic cancer cells in hypoglucose. Co-author DOI 10.1038/s41419-017-0158-5↗
  7. ASIC1 and ASIC3 contribute to acidity-induced EMT of pancreatic cancer through activating Ca2+/RhoA pathway. Co-author DOI 10.1038/cddis.2017.189↗
  8. MiR-548an, Transcriptionally Downregulated by HIF1α/HDAC1, Suppresses Tumorigenesis of Pancreatic Cancer by Targeting Vimentin Expression. Co-author DOI 10.1158/1535-7163.mct-15-0877↗
  9. Hypoxia-induced lncRNA-NUTF2P3-001 contributes to tumorigenesis of pancreatic cancer by derepressing the miR-3923/KRAS pathway. First author DOI 10.18632/oncotarget.6830↗
  10. Chronic pancreatitis and pancreatic cancer demonstrate active epithelial-mesenchymal transition profile, regulated by miR-217-SIRT1 pathway. Co-author DOI 10.1016/j.canlet.2014.08.007↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gang Zhao · 10 shared papers, 2014–2019 · strength 0.66
  2. Chunyou Wang · 9 shared papers, 2014–2019 · strength 0.56
  3. Mingliang Liu · 7 shared papers, 2016–2019 · strength 0.51
  4. Shichang Deng · 8 shared papers, 2014–2019 · strength 0.49
  5. Shuai Zhu · 7 shared papers, 2014–2019 · strength 0.44
  6. Zhu Zeng · 6 shared papers, 2016–2019 · strength 0.44
  7. Ye Zeng · 5 shared papers, 2018–2019 · strength 0.39
  8. Xiang Li · 6 shared papers, 2014–2018 · strength 0.34
  9. Fengyu Xu · 4 shared papers, 2018–2019 · strength 0.32
  10. Yan Jin · 5 shared papers, 2014–2018 · strength 0.29
  11. Qiang Li · 2 shared papers, 2018–2019 · strength 0.15
  12. Qi Qin · 2 shared papers, 2014–2018 · strength 0.11
  13. Qiang Li · 1 shared paper, 2019 · strength 0.09
  14. Wei Li · 1 shared paper, 2019 · strength 0.08
  15. Yuhang Hu · 1 shared paper, 2019 · strength 0.08
  16. Yi Niu · 1 shared paper, 2018 · strength 0.07
  17. Yang Liu · 1 shared paper, 2016 · strength 0.05
  18. Shuai Zhu · 1 shared paper, 2016 · strength 0.05
  19. Ming Yang · 1 shared paper, 2014 · strength 0.03
  20. Tao Yin · 1 shared paper, 2014 · strength 0.03
  21. Heshui Wu · 1 shared paper, 2014 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.